Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Am J Prev Med. 2019 Mar 16;56(5):655–663. doi: 10.1016/j.amepre.2018.12.004

Table 1.

Characteristics of Young Adult Past Year Cigarette Smokers by Past Year Use of E-cigarettes

Characteristic Past year smokers
without past year
e-cigarette use
% (N=2,916)
Past year smokers
with past year e-
cigarette use
% (N=571)
 OR (95% CI)
(ref=no e-
cigarettes)
Age, years
 18–25 39.6 46.8 1.34 (1.10, 1.63)
 26–35 60.4 53.2 1.00
Sex
 Male 53.6 60.5 1.33 (1.06, 1.67)
 Female 46.4 39.5 1.00
Race/Ethnicity
 White 66.3 73.8 1.00
 Black 12.6 6.4 0.45 (0.33, 0.62)
 Hispanic 15.8 11.3 0.64 (0.47, 0.88)
 Other 5.3 8.6 1.44 (0.94, 2.21)
Education (at interview)
 Less than high school 18.4 12.0 0.58 (0.40, 0.84)
 High school 23.7 23.4 0.89 (0.70, 1.12)
 At least some college 57.9 64.6 1.00
Personal income
 $0–$19,999 57.7 61.0 1.24 (0.89, 1.73)
 $20,000–$39,999 29.0 27.7 1.12(0.77, 1.63)
 ≥$40,000 13.3 11.4 1.00
Marital status
 Married or cohabiting 42.2 35.7 1.00
 Widowed, separated, 9.5 11.0 1.37 (0.89, 2.09)
 divorced
 Never married 48.3 53.3 1.30 (1.01, 1.68)
Behavioral health disorders
 Drug use disorder, lifetime 28.3 38.0 1.55 (1.25, 11.92)
 Alcohol use disorder, lifetime 55.8 70.8 1.92 (1.56, 2.37)
 Depressive disorder, lifetime 26.5 28.1 1.08 (0.85, 1.39)
 Anxiety disorder, lifetime 22.0 25.6 1.22 (0.94, 1.59)
Tobacco use
 Age (SD) started daily cigarette smoking, years 18.2 (7.9) 17.2 (3.4) t=3.23, p=0.002
 Heavy smoker, past year 3.8 5.9 1.57 (0.91, 2.70)
 Tobacco use disorder, past year 75.1 89.9 2.96 (2.02, 4.34)
  Mild 62.4 43.3 1.00
  Moderate 21.1 24.0 1.64 (1.27, 2.11)
  Severe 16.5 32.6 2.84 (2.23, 3.61)
  Daily cigarette smoker, past year 69.3 78.4 1.61 (1.26, 2.05)
  Mean (SD) number of cigarettes/day, past year 12.0 (8.0) 13.2 (7.6) t=2.76, p=0.007

Note: Boldface indicates statistical significance (p<0.05). Data from NESARC-III. Results are unadjusted.

NESARC-III, National Epidemiologic Survey on Alcohol and Related Conditions-III.